Back to resultsTCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
Primary Purpose
Liver Cirrhosis
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Fuzhenghuayu Tablet, Huangqi Decoction Granule
Sponsored by
About this trial
This is an interventional treatment trial for Liver Cirrhosis
Eligibility Criteria
Inclusion Criteria:
- With 6 month of chronic liver disease history, and positive serum HBsAg
Exclusion Criteria:
- Other chronic hepatitis and liver cirrhosis of non-hepatitis B
Sites / Locations
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese MedicineRecruiting
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00540397
First Posted
October 5, 2007
Last Updated
October 5, 2007
Sponsor
Shanghai University of Traditional Chinese Medicine
1. Study Identification
Unique Protocol Identification Number
NCT00540397
Brief Title
TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
Official Title
Traditional Chinese Medicine Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
Study Type
Interventional
2. Study Status
Record Verification Date
October 2007
Overall Recruitment Status
Unknown status
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Shanghai University of Traditional Chinese Medicine
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To Elucidate and Confirm the Theory of XuSunShengJi in the Traditional Chinese Medicine Etiological Pathogenesis of Liver Cirrhosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Cirrhosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Fuzhenghuayu Tablet, Huangqi Decoction Granule
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
With 6 month of chronic liver disease history, and positive serum HBsAg
Exclusion Criteria:
Other chronic hepatitis and liver cirrhosis of non-hepatitis B
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lie-ming Xu, Professor
Phone
00-86-21-51328888
Ext
8112
Email
xulieming@shutcm.edu.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ping Liu, Professor
Organizational Affiliation
Shanghai University of Traditional Chinese Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200021
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lie-ming Xu, Professor
Phone
0086-21-51328888
Ext
8112
12. IPD Sharing Statement
Learn more about this trial
TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
We'll reach out to this number within 24 hrs